Ownership history in VR Adviser, LLC · 21 quarters on record
This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in VIRIDIAN THERAPEUTICS INC (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 3,882,709 | — | 0% | 5.97% | $120.8M | $31.12 |
| 2025 Q3 | UNCHANGED | 3,882,709 | — | 0% | 4.72% | $83.8M | $21.58 |
| 2025 Q2 | UNCHANGED | 3,882,709 | — | 0% | 4.07% | $54.3M | $13.98 |
| 2025 Q1 | UNCHANGED | 3,882,709 | — | 0% | 4.45% | $52.3M | $13.48 |
| 2024 Q4 | UNCHANGED | 3,882,709 | — | 0% | 5.11% | $74.4M | $19.17 |
| 2024 Q3 | ADDED | 3,882,709 | +38 | +0.0% | 4.63% | $88.3M | $22.75 |
| 2024 Q2 | UNCHANGED | 3,882,671 | — | 0% | 3.22% | $50.5M | $13.01 |
| 2024 Q1 | ADDED | 3,882,671 | +48 | +0.0% | 3.23% | $68.0M | $17.51 |
| 2023 Q4 | ADDED | 3,882,623 | +800,001 | +26.0% | 5.80% | $84.6M | $21.78 |
| 2023 Q3 | UNCHANGED | 3,082,622 | — | 0% | 4.98% | $47.3M | $15.34 |
As of 2025 Q4 — sorted by position size